Gland Pharma receives 2 observations under 483 for Pashamylaram facility
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
The inspection closed with zero observations and a classification of No Action Indicated
Take proper precautions and seek timely treatment!
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Mix-n-Stain CF Dye IgM Antibody Labeling Kits address longstanding challenges for labeling IgM antibodies by offering efficient and convenient conjugation with bright CF Dyes
Subscribe To Our Newsletter & Stay Updated